Lung Transplantation: CT Assessment of Chronic Lung Allograft Dysfunction (CLAD).
Anne-Laure BrunMarie Laure ChabiClément PicardFrançois MellotPhilippe A GrenierPublished in: Diagnostics (Basel, Switzerland) (2021)
Chronic lung allograft rejection remains one of the major causes of morbi-mortality after lung transplantation. The term Chronic Lung Allograft Dysfunction (CLAD) has been proposed to describe the different processes that lead to a significant and persistent deterioration in lung function without identifiable causes. The two main phenotypes of CLAD are Bronchiolitis Obliterans Syndrome (BOS) and Restrictive Allograft Syndrome (RAS), each of them characterized by particular functional and imaging features. These entities can be associated (mixed phenotype) or switched from one to the other. If CLAD remains a clinical diagnosis based on spirometry, computed tomography (CT) scan plays an important role in the diagnosis and follow-up of CLAD patients, to exclude identifiable causes of functional decline when CLAD is first suspected, to detect early abnormalities that can precede the diagnosis of CLAD (particularly RAS), to differentiate between the obstructive and restrictive phenotypes, and to detect exacerbations and evolution from one phenotype to the other. Recognition of early signs of rejection is crucial for better understanding of physiopathologic pathways and optimal management of patients.
Keyphrases
- computed tomography
- lung function
- chronic obstructive pulmonary disease
- dual energy
- cystic fibrosis
- image quality
- positron emission tomography
- contrast enhanced
- kidney transplantation
- magnetic resonance imaging
- extracorporeal membrane oxygenation
- ejection fraction
- air pollution
- high resolution
- preterm infants
- drug induced
- patient reported outcomes
- gestational age
- patient reported
- photodynamic therapy